Brian Nowosielski

Researchers address the potential association of access to maternal care with the increased risk of infant mortality.

With disease cases increasing substantially between 2012 and 2024, higher-valent vaccines are necessary to protect against nonvaccine serotypes and invasive pneumococcal disease.

Due to the lived realities and trajectory of risk throughout their lifetime, researchers believe women require novel approaches in their cardiovascular health care needs.

Researchers explore highly engaged social media posts related to glucagon-like peptide-1 receptor agonists, attention deficit/hyperactivity disorder stimulants, and autoimmune biologics.

This episode explores ongoing developments in pharmacy law, specifically for independent pharmacies and their representatives who attended the 2025 NCPA Convention & Expo.

This collaboration is designed to bring resources addressing pharmacy shortages to the fingertips of the general public.

The event will explore the importance of advocacy, gathering experts all across community pharmacy to discuss improving patient access and education.

With a new year approaching, pharmacy law experts joined Over the Counter to recap some of the key events regarding state- and federal-level PBM reform throughout 2025.

With evidence of antiobesity properties in human trials, berberine could be an OTC phytotherapeutic option for weight loss.

Steve Leonard, PharmD, BCIDP, joins Drug Topics on World Pneumonia Day to discuss pharmacists’ role in managing the disease.

Study findings highlight the need for further exploration into the racial and ethnic trends of pneumococcal vaccination rates.

To celebrate World Pneumonia Day, Steve Leonard, PharmD, BCIDP, joined us to discuss the variety of pneumonia types and the treatment options commonly prescribed.

In patients with diabetes and various levels of UACR, researchers aimed to uncover both the relative and absolute effects of SGLT2 inhibitors.

A study explored how SGLT2 inhibitors impact the kidney, specifically whether effects varied by estimated glomerular filtration rate (eGFR) or albuminuria.

A secondary analysis of the obesity-fertility lifestyle intervention program explored how it impacted the behavior of women with obesity and subfertility.

The NCPDP gathered essential members from the pharmacy community in a roundtable discussion on electronic prior authorizations.

This episode explores the complex composition of a good leader within the pharmacy industry.

Living in West Virginia for over a decade, Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his experience as a practicing pharmacist amid the US opioid crisis.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his pain management expertise and discusses current developments in the US opioid epidemic.

Researchers investigate women’s experiences in accessing either prescription or OTC contraceptives.

To optimize vaccine strategies among young people with Down syndrome, researchers explore the prevalence of adequate immune responses following pneumococcal vaccination.

Through diabetes education and initiatives focused on community health care, Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, is making a difference for patients and the pharmacy profession.

Episode 4 of Wicked Good Cardiometabolic Chat explores SGLT2 inhibitors and their efficacy beyond diabetes outcomes alone.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses risks and approaches associated with severe insulin resistance among mothers and their children.

Due to humans’ physiologically premature nature, researchers explore maternal psychological distress and childhood neurodevelopment.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses the Touro University California, pharmacist-led Pharm2Home initiative.

Researchers explore OTC naloxone sales sold independently at pharmacies and programmatically from 2023 to 2024.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses his experience in diabetes care and how the pharmacist’s role has evolved throughout his professional career.

Lisa Schwartz, PharmD, discusses her general opinions regarding how the predicted success of the Medicare Drug Price Negotiation Program’s future implementation.

Lisa Schwartz, PharmD, discusses community pharmacies’ displeasure with provisions backing the Medicare Drug Price Negotiation Program.